Intralymphatic allergen administration renders
specific immunotherapy faster and safer: A randomized controlled trial - Gabriela Senti, Bettina M. Prinz Vavricka, Iris Erdmanna, Mella I. Diaz, Richard Markus, Stephen J. McCormack, John J. Simarda, Brunello Wüthrich, Reto Crameri, Nicole Graf, Pål Johansen, and Thomas M. Kündig [1]